These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4293024)

  • 1. Studies on characteristics of poliovirus. II. Plaque-forming capacity of attenuated poliovirus strains in human and monkey kidney cell cultures.
    Böttiger M
    Arch Gesamte Virusforsch; 1966; 18(2):127-34. PubMed ID: 4293024
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on characteristics of poliovirus. I. Marker and temperature.
    Böttiger M
    Arch Gesamte Virusforsch; 1966; 18(2):119-26. PubMed ID: 4293703
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on characteristics of poliovirus. 3. Investigation of d, rct, h and n markers of poliovirus isolated after vaccination with the Type 1, Chat strain.
    Böttiger M
    Arch Gesamte Virusforsch; 1966; 18(2):135-54. PubMed ID: 4293025
    [No Abstract]   [Full Text] [Related]  

  • 4. Investigation of some possibilities of producing type 3 vaccine poliovirus with greater genetic stability. I. Preliminary experiments with passage variants.
    Elbert LB; Chumakov MP; Krutyanskaya GL; Ralph NM; Tyufanov AV
    Acta Virol; 1968 May; 12(3):193-202. PubMed ID: 4385148
    [No Abstract]   [Full Text] [Related]  

  • 5. New trends in the preparation of cell substrates for the production of virus vaccines.
    van Wezel AL
    Prog Immunobiol Stand; 1971; 5():187-92. PubMed ID: 4349819
    [No Abstract]   [Full Text] [Related]  

  • 6. Preliminary results on the use of human diploid fibroblasts for inactivated polio virus vaccine production.
    Larsson B; Litwin J
    Dev Biol Stand; 1980; 46():241-7. PubMed ID: 6245000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Present state and developments in the production of inactivated poliomyelitis vaccine.
    van Wezel AL
    Dev Biol Stand; 1981; 47():7-13. PubMed ID: 6262162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monkey kidney cell growth optimization and poliovirus propagation in microcarrier culture.
    Mered B; Albrecht P; Hopps HE; Petricciani JC; Salk J
    Dev Biol Stand; 1981; 47():41-53. PubMed ID: 6262160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DEXTRAN SULFATE PLAQUE VARIANTS OF ATTENUATED TYPE 1 POLIOVIRUS. RELATIONSHIP TO IN VITRO AND IN VIVO MARKERS.
    TAKEMOTO KK; KIRSCHSTEIN RL
    J Immunol; 1964 Feb; 92():329-33. PubMed ID: 14160455
    [No Abstract]   [Full Text] [Related]  

  • 10. Plaque cinetic index in cultures under agar.
    Santoro R; Mancini G; Balducci D
    Experientia; 1965 May; 21(5):279-80. PubMed ID: 4284690
    [No Abstract]   [Full Text] [Related]  

  • 11. Aluminum-marker of wild type 1 poliovirus strains.
    Nakao C; Tagaya I; Komatsu T; Kodama H
    Jpn J Microbiol; 1970 Sep; 14(5):405-12. PubMed ID: 4319729
    [No Abstract]   [Full Text] [Related]  

  • 12. CHARACTERISTICS OF ATTENUATED TYPE 3 POLIOVIRUS OBTAINED BY ALTERNATE PASSAGES IN CHICK CELL CULTURES AND MONKEY KIDNEY CELL CULTURES.
    TAKAHASHI M; HAMADA T; OKABE S
    Biken J; 1963 Oct; 6():219-22. PubMed ID: 14147715
    [No Abstract]   [Full Text] [Related]  

  • 13. [STUDIES ON TESTING THE SAFETY OF INACTIVATED POLIOMYELITIS VACCINE. III. IS THERE INTERFERENCE BY SV 40 AGAINST POLIOVIRUS?].
    GUENTHER O; VON METTENHEIM ; HOEVEL H
    Zentralbl Bakteriol Orig; 1964 Feb; 192():1-11. PubMed ID: 14176847
    [No Abstract]   [Full Text] [Related]  

  • 14. The production of inactivated poliovaccine on serially cultivated kidney cells from captive-bred monkeys.
    van Wezel AL; van der Velden-de Groot CA; van Herwaarden JA
    Dev Biol Stand; 1980; 46():151-8. PubMed ID: 6244995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell substrate for killed poliovaccine production.
    Beale AJ
    Dev Biol Stand; 1981; 47():19-23. PubMed ID: 6262147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plaque formation by poliovirus cultivated in monkey kidney culture on a methylcellulose containing medium].
    Hövel H; Günther O
    Zentralbl Bakteriol Orig; 1964 Dec; 195(2):149-56. PubMed ID: 4284126
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of proflavine-sensitized poliovirus strains for determination of the range of susceptible animals.
    Koroleva GA; Lashkevich VA; Voroshilova MK
    Acta Virol; 1973 Jul; 17(4):310-8. PubMed ID: 4148211
    [No Abstract]   [Full Text] [Related]  

  • 18. Production of high titer attenuated poliovirus strains on the serum-free PER.C6(®) cell culture platform for the generation of safe and affordable next generation IPV.
    Sanders BP; Oakes Ide L; van Hoek V; Liu Y; Marissen W; Minor PD; Wimmer E; Schuitemaker H; Custers JH; Macadam A; Cello J; Edo-Matas D
    Vaccine; 2015 Nov; 33(48):6611-6. PubMed ID: 26529068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propagation of poliovirus in microcarrier cultures of three monkey kidney cell lines.
    Mered B; Albrecht P; Hopps HE; Petricciani JC; Salk J
    J Biol Stand; 1981; 9(2):137-45. PubMed ID: 6263932
    [No Abstract]   [Full Text] [Related]  

  • 20. [Study of the biological properties of vaccinal strains of type 3 poliomyelitis virus isolated from children in Sverdlovsk].
    Shchekochikhina EA; Dodonova NN; Dzagurov SG; Omel'chenko TN; Tsetlin EM
    Vopr Virusol; 1973; 18(4):484-9. PubMed ID: 4362265
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.